139 related articles for article (PubMed ID: 33256609)
21. Prevalence and risk factors for secondary hypertension among young Korean men.
Kim K; Kim JY; Choi EY; Kwon HM; Rim SJ
Rev Cardiovasc Med; 2020 Dec; 21(4):627-634. PubMed ID: 33388008
[TBL] [Abstract][Full Text] [Related]
22. Comments on "Diet quality in relation to the risk of hypertension among Iranian adults: cross-sectional analysis of Fasa PERSIAN cohort study".
Ghobadi S; Jafari A
Nutr J; 2022 Jun; 21(1):41. PubMed ID: 35725533
[No Abstract] [Full Text] [Related]
23. Correlation of resting heart rate with anthropometric factors and serum biomarkers in a population-based study: Fasa PERSIAN cohort study.
Goorakani Y; Sedigh Rahimabadi M; Dehghan A; Kazemi M; Chijan MR; Bijani M; Shahraki HR; Davoodi A; Farjam M; Homayounfar R
BMC Cardiovasc Disord; 2020 Jul; 20(1):319. PubMed ID: 32631242
[TBL] [Abstract][Full Text] [Related]
24. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
Ene-Iordache B; Perico N; Bikbov B; Carminati S; Remuzzi A; Perna A; Islam N; Bravo RF; Aleckovic-Halilovic M; Zou H; Zhang L; Gouda Z; Tchokhonelidze I; Abraham G; Mahdavi-Mazdeh M; Gallieni M; Codreanu I; Togtokh A; Sharma SK; Koirala P; Uprety S; Ulasi I; Remuzzi G
Lancet Glob Health; 2016 May; 4(5):e307-19. PubMed ID: 27102194
[TBL] [Abstract][Full Text] [Related]
25. Examining the association between opium use, cigarette smoking and alcohol consumption with the liver enzyme levels in a population-based study: Fasa Persian cohort data.
Bijani M; Dehghan A; Razavi S; Karimi S
BMC Res Notes; 2022 Jan; 15(1):2. PubMed ID: 34986881
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Different Obesity Indices for Predicting Incident Hypertension.
Janghorbani M; Aminorroaya A; Amini M
High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):157-166. PubMed ID: 28160265
[TBL] [Abstract][Full Text] [Related]
27. Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study.
Barua L; Faruque M; Banik PC; Ali L
Medicina (Kaunas); 2019 Jun; 55(7):. PubMed ID: 31248050
[No Abstract] [Full Text] [Related]
28. Prevalence and Determinants of Hypertension among Iranian Adults, Birjand, Iran.
Kazemi T; Hajihosseini M; Mashreghimoghadam H; Azdaki N; Ziaee M
Int J Prev Med; 2017; 8():36. PubMed ID: 28584618
[TBL] [Abstract][Full Text] [Related]
29. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
Janghorbani M; Amini M
Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of hypertension and related risk factors in central Iran: Results from Yazd Health Study.
Mirzaei M; Mirzaei M; Gholami S; Abolhosseini H
ARYA Atheroscler; 2021 Jan; 17(1):1-9. PubMed ID: 34703488
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
[TBL] [Abstract][Full Text] [Related]
32. Lipid profile dysregulation in opium users based on Fasa PERSIAN cohort study results.
Kazemi M; Bazyar M; Naghizadeh MM; Dehghan A; Rahimabadi MS; Chijan MR; Bijani M; Zahmatkeshan M; Ghaemi A; Samimi N; Homayounfar R; Farjam M
Sci Rep; 2021 Jun; 11(1):12058. PubMed ID: 34103610
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Risk Factors Associated With Hypertension in von Willebrand Disease.
Apostolova MH; Seaman CD; Comer DM; Yabes JG; Ragni MV
Clin Appl Thromb Hemost; 2018 Jan; 24(1):93-99. PubMed ID: 27655998
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and risk factors of kidney stone disease in population aged 40-70 years old in Kharameh cohort study: a cross-sectional population-based study in southern Iran.
Moftakhar L; Jafari F; Ghoddusi Johari M; Rezaeianzadeh R; Hosseini SV; Rezaianzadeh A
BMC Urol; 2022 Dec; 22(1):205. PubMed ID: 36536352
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of hypertension in an Iranian population.
Aghaei Meybodi HR; Khashayar P; Rezai Homami M; Heshmat R; Larijani B
Ren Fail; 2014 Feb; 36(1):87-91. PubMed ID: 24028502
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and treatment of hypertension in urban and riverside areas in Porto Velho, the Brazilian Amazon.
Almeida RC; Dias DJ; Deguchi KT; Spesia CH; Coelho OR
Postgrad Med; 2015 Jan; 127(1):66-72. PubMed ID: 25526235
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of hypertension in suspected hypertensive patients in Rajavithi Hospital using ambulatory blood pressure monitoring.
Pengkeaw P; Suwannakarn S
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S25-30. PubMed ID: 25509692
[TBL] [Abstract][Full Text] [Related]
38. Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal.
Polónia J; Carvalho D; Nazaré J; Martins L; da Silva PM; Aguiar C; Manso MC; Carqueja T
J Hum Hypertens; 2016 Nov; 30(11):726-730. PubMed ID: 26740337
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of hypertension among Iranian hemodialysis patients and associated risk factors: a nationwide multicenter study.
Nemati E; Ghanbarpour F; Taheri S; Einollahi B
Pak J Biol Sci; 2008 Mar; 11(6):910-4. PubMed ID: 18814655
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and Associated Factors of Prehypertension and Hypertension in Iranian Population: The Lifestyle Promotion Project (LPP).
Tabrizi JS; Sadeghi-Bazargani H; Farahbakhsh M; Nikniaz L; Nikniaz Z
PLoS One; 2016; 11(10):e0165264. PubMed ID: 27783691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
